Graves’ disease is the commonest form of hyperthyroidism in which excessive production of thyroid hormones by the hyperplastic overactive thyroid gland produces elevated serum levels of the thyroid hormones tri-iodothyronine (T3) and thyroxine (T4). Many of the manifestations of Graves’ disease, increased basal metabolic rate, increased heart rate, heat intolerance, sweating and nervousness, can be attributed to the peripheral actions of the excess thyroid hormones. The pathogenesis of many of the other dramatic features of Graves’ disease, such as the eye involvement or localized skin changes, is not fully understood, but circulating immunoglobulins with thyroid stimulating activity are almost certainly linked to excess thyroid hormone production and thereby cause the hyperthyroidism.
Skip Nav Destination
Article navigation
Other|
August 01 1985
Thyroid Stimulating Immunoglobulins: Measurement and Clinical use
C. A. Ollis;
C. A. Ollis
1Department of Medicine, Clinical Sciences Centre, Northern General Hospital, Sheffield, U.K.
Search for other works by this author on:
S. Tomlinson;
S. Tomlinson
*University Department of Medicine, Manchester Royal Infirmary, Manchester. U.K.
Search for other works by this author on:
D. S. Munro
D. S. Munro
1Department of Medicine, Clinical Sciences Centre, Northern General Hospital, Sheffield, U.K.
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© 1985 The Biochemical Society and the Medical Research Society
1985
Clin Sci (Lond) (1985) 69 (2): 113–121.
Citation
C. A. Ollis, S. Tomlinson, D. S. Munro; Thyroid Stimulating Immunoglobulins: Measurement and Clinical use. Clin Sci (Lond) 1 August 1985; 69 (2): 113–121. doi: https://doi.org/10.1042/cs0690113
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |